2023: Stella Robertson, PhD

Stella Robertson has over 25 years of experience in pharmaceutical Research and Development, including R&D strategies, project management, clinical trials, regulatory filings for US and international registrations, product launch, market support, translational medicine and medical communication. Currently, Dr. Robertson is a member and investor with Cowtown Angels and the owner of Arrochar Consulting.

She formerly was a Vice President in Research and Development at Alcon Laboratories, Inc., a Division of Novartis, where she grew and led organizations that were responsible for the ophthalmic pipeline, otic pharmaceuticals, and medical devices. During her tenure at Alcon, she and her colleagues successfully developed, registered, and globally launched sixteen ophthalmic medications, and also treatments for otitis media and nasal allergy.

She received a Ph.D. in Biology-Immunology from Johns Hopkins University, is an adjunct member of the Ophthalmology Department of UTHSCD Southwestern Medical School, and a volunteer in the University of North Texas Health Science Center translational research and entrepreneurial program. She holds a number of patents and is the author or co-author of over 50 publications.